Does Percutaneous Neuromodulation Promote Recovery in Hockey Players With Grade 0 Adductor Injuries?
1 other identifier
interventional
11
1 country
1
Brief Summary
Ice hockey is a widely practiced sport, particularly in North America and Europe, with over 2,500 professional players in North America and approximately 2,000 in Europe. Its global expansion has extended participation to regions such as Africa and Australia. This sport demands high physical performance, speed, strategy, and specific preparation to prevent injuries. The most common injuries include muscular and joint trauma, especially in the knees, shoulders, and groin region, where "groin pain" is a frequent issue. Injuries to the hip joint, such as femoroacetabular impingement (FAI), acetabular labrum and cartilage lesions, and intra-articular loose bodies, are prevalent. Extra-articular injuries primarily involve the adductor and abdominal muscles. The biomechanics of ice skating require repetitive and forceful hip movements, increasing eccentric load on the adductors, particularly at higher skating speeds, thereby raising the risk of strains. Studies have shown that the adductor muscles, particularly the adductor longus, are the most frequently injured. Risk factors include a history of previous injury, high training intensity, strength imbalances between adductors and abductors, and inadequate preseason preparation. A critical threshold is the adductor/abductor strength ratio: if it falls below 80%, the risk of injury increases 17-fold. Invasive physiotherapy has gained prominence as an effective option for the treatment and prevention of such injuries. Ultrasound-guided invasive techniques, such as ultrasound-guided percutaneous neuromodulation (US-guided PNM), have demonstrated the ability to reduce muscle stiffness, improve intra- and intermuscular coordination, and enhance endurance. These techniques have shown greater efficacy than conventional methods, contributing to improved athletic performance and reduced injury risk. US-guided PNM is a minimally invasive technique that delivers electrical stimulation via needles placed under ultrasound guidance near peripheral nerves or motor points. The stimulation is adjusted according to therapeutic goals, whether to reduce pain, improve neuromuscular function, or modulate muscle tone. Its efficacy has been documented in studies showing improvements in flexibility, strength, and post-exertion recovery, with effects observed even in the contralateral limb, attributed to the crossover phenomenon. Given the high incidence of adductor injuries among hockey players and the associated risk factors, this clinical study aimed to evaluate the effectiveness of a single session of US-guided PNM in players with grade 0 (muscle contracture) injuries of the adductor muscles. Three primary variables were assessed: muscle strength (Adductor Squeeze Test), hip mobility (Bent Knee Fall Out Test), and subjective pain (VAS scale), both in daily activities and during on- and off-ice training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2025
CompletedStudy Start
First participant enrolled
June 27, 2025
CompletedFirst Posted
Study publicly available on registry
July 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedJanuary 20, 2026
January 1, 2026
2 months
June 27, 2025
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
VAS (ADL)
Pain during the activities of the daily life. This variable will be assessed through the Visual Analogue Scale (0-10 points)
2 times, immediately pre-intervention and immediately after the first training posterior to the intervention.
VAS (ON ice)
Pain during hockey training on ice. This variable will be assessed through the Visual Analogue Scale (0-10 points)
2 times, immediately pre-intervention and immediately after the first training posterior to the intervention.
VAS (OFF ice)
Pain during training out of the ice. This variable will be assessed through the Visual Analogue Scale (0-10 points)
2 times, immediately pre-intervention and immediately after the first training posterior to the intervention.
Secondary Outcomes (2)
Maximum Isometric Strength. Hip Adductors
2 times, immediately pre-intervention and immediately post-intervention
Passive hip mobility
2 times, immediately pre-intervention and immediately post-intervention.
Study Arms (1)
US-guided PNM
EXPERIMENTALEach participant will be treated with US-guided PNM targeting the anterior branch of the obturator nerve.
Interventions
Stimulation will be applied for 15 minutes at 4 Hz, using a 250 ms pulse duration.
Eligibility Criteria
You may qualify if:
- Age over 18 years
- Pain in the adductor region
- Clinical diagnosis with ultrasound confirmation of the absence of structural damage, consistent with a grade 0 muscle injury (contracture) localized in the adductors
You may not qualify if:
- Presence of muscle injuries above grade 0
- Concomitant neurological, systemic, or orthopedic conditions
- Recent application of neuromodulation techniques or other similar treatments performed by healthcare professionals within the last 7 days
- Belonephobia (fear of needles)
- Infections or skin disorders localized in the inguinal region
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Zaragoza
Zaragoza, 50006, Spain
Study Officials
- STUDY DIRECTOR
Pablo Herrero, Physiotherapist
Universidad de Zaragoza
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 27, 2025
First Posted
July 24, 2025
Study Start
June 27, 2025
Primary Completion
September 1, 2025
Study Completion
October 1, 2025
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Once research has been published
- Access Criteria
- Study protocol will be publish in a scientific journal
Data will be shared on a reasonable request contacting with the main author once data has been published. Anyway, Individual participant data (IPD) will be shared with other researchers in accordance with data sharing protocols and participant consent, ensuring confidentiality and ethical considerations are maintained.